Home > About Life After Early Breast Cancer > Expert Advisors |
 |
Expert Advisors
|
Andrea Gurmankin, Ph.D, MBe
Andrea Gurmankin, Ph.D, MBe, is an assistant professor of Society, Human Development and Health at the Harvard School of Public Health and a faculty member in the Center for Community-Based Research (CCBR) at the Dana-Farber Cancer Institute in Boston. After earning her undergraduate degree in Biology and Society at Cornell University, Dr. Gurmankin received her Ph.D and MBe at the University of Pennsylvania in 2003.
A widely published author, Dr. Gurmankin has contributed to several key texts in medicine and bioethics, including: Archives of Internal Medicine, Journal of General Internal Medicine, American Journal of Bioethics, Politics and the Life Sciences, Medical Decision-Making and Human Reproduction. Additionally, she has several articles currently in press and under review: Journal of Behavioral Decision-Making (review), American Journal of Preventive Medicine (review), Journal of Clinical Oncology (review).
Dr. Gurmankin is a prolific contributor to her field. In addition to her academic duties, she is involved in various research projects. Her research interests are cancer risk perception and risk communication, and their impact on patients' medical decisions and health behaviors. Dr. Gurmankin is also interested in medical ethics, particularly informed consent, patient autonomy and reproductive ethics. |
Sherry A. Marts, Ph.D.
Society for Women's Health Research
Vice President, Scientific Affairs
Sherry Marts directs scientific programs at the Society, including the Society's conference series on sex-based biology, the "Some Things Only a Woman Can Do" public education campaign on clinical trials, conferences on Sex and Gene Expression (SAGE), and the Isis Fund for Women's Health Research. She serves as scientific spokesperson for the Society.
Prior to joining the Society as scientific director in 1998, Marts was a senior analyst at the consulting firm of Abt Associates, where she served as scientific research administrator for the HIV Network for Prevention Trials, under a contract with the National Institute of Allergy and Infectious Diseases. From 1991-1996, she was director of research grants at the American Health Assistance Foundation. From 1988-1991, she worked in the office of the vice president for research and development at the American Red Cross biomedical research laboratories in Rockville, Md., where she managed the Red Cross intramural research grants program and administered the Red Cross research ethics review and training programs. She later returned to the Red Cross as a consultant in research ethics and regulatory affairs.
Marts received a bachelor's of science in applied biology from The Hatfield Polytechnic (now Hertfordshire University, UK) in 1981 and her doctorate in cell and molecular biology from Duke University in 1986. She completed a postdoctoral fellowship at the Lineberger Cancer Research Center at the University of North Carolina at Chapel Hill in 1988. |
Ursula Matulonis, M.D.
Ursula Matulonis, M.D., is the Director of Medical Gynecologic Oncology at the Dana-Farber Cancer Institute in Boston and an Assistant Professor of Medicine at Harvard Medical School. After earning her medical degree at Albany Medical College in New York, Dr. Matulonis completed her internship and residency at the University of Pittsburgh and trained as a clinical fellow in Medical Oncology at the Dana-Farber Cancer Institute.
A widely published author, Dr. Matulonis has contributed to several key texts in medicine and oncology, including: Journal of Clinical Oncology, Annals of Oncology, International Journal of Gynecological Cancer and Gynecologic Oncology and to various academic texts including Lifestyle Medicine and Atlas of Diagnostic Oncology. In addition, she is an ad hoc reviewer of the New England Journal of Medicine, American Journal of Medicine and Journal of Clinical Oncology.
Dr. Matulonis is a prolific contributor to her field. She has presented research at medical meetings, including the American Society of Clinical Oncology Annual Meeting (ASCO) and the American Society of Hematology (ASH) annual meeting and is involved in clinical research projects and laboratory collaborations, where she is the primary investigator (PI) and co-PI of several gynecologic and breast cancer trials.
In addition to her professional duties, Dr. Matulonis is a member of several professional societies including: American Society of Breast Disease, American Society of Clinical Oncology, Society of Gynecologic Oncology, International Society for Geriatric Oncology, AACR and the Society for Medical Decision Marking. She also sits on the Ovarian Cancer Recommendation and Guideline Committee of the National Comprehensive Cancer Network (NCCN) and is a member of the Gynecologic Oncology Group QOL committee.
In recognition of her numerous contributions to the medical field, Dr. Matulonis has received several awards, including Boston Magazine's "Best Physicians in Boston" for medical oncology (Feb 2002), the Partners HealthCare System's "Partners in Excellence Award" in 2000 and the "Dennis Thomson Compassionate Care Scholar" award in 2000 from Brigham and Women's Hospital in Boston. |
Linda T. Vahdat, M.D.
Dr. Vahdat is director of the breast cancer research program and associate professor of medicine at Weill Medical College of Cornell University. Her research interests include breast cancer, autologous transplants, hematopoietic stem cells, gene therapy, anti-angiogenesis and new technology.
She is a member of numerous medical societies including the American Society of Clinical Oncology (ASCO), and she is also associate editor of Patients Living With Cancer, an ASCO Web site (plwc.org). Dr. Vahdat has published many articles in books and peer-reviewed journals, including Cancer, Leukemia, and Bone Marrow Transplantation.
She received her undergraduate degree from Barnard College in New York City and went on to complete her medical training at the Mount Sinai School of Medicine. She remained at Mount Sinai for her residency training in internal medicine followed by fellowship training in medical oncology and hematology at the Memorial Sloan-Kettering Cancer Center. She is board certified in internal medicine and medical oncology. |
|
|
